Viseon Spine Closes $5.0M Series A Financing

Viseon Spine Incorporated, an Irvine, California-based medical device company, closed a $5.0m Series A financing.

The round was led by HBM-MedFocus (Irvine, CA), Invus Opportunities Fund (New York, NY), and affiliates of Wexford Capital LP (Greenwich, CT and West Palm Beach, FL).

The company intends to use the funds for ongoing product development, worldwide regulatory approvals, clinical evaluations and initial manufacturing scale-up and commercialization efforts.

Founded in early 2017 as a spin-out from Rebound Therapeutics Corporation, and led by Jeffrey Valko, President and CEO, Viseon has developed devices to improve the procedural and clinical outcomes of many minimally invasive spine surgery procedures.
The company has assembled a Scientific Advisory Board of MISS physicians, amassed 13 patents to consolidate its intellectual property platform, and completed a series of pre-clinical studies supporting initial human-use, scheduled to begin soon.



Join the discussion